CORT Annual Total Long Term Liabilities
$10.31 M
+$1.21 M+13.30%
31 December 2023
Summary:
As of January 23, 2025, CORT annual total long term liabilities is $10.31 million, with the most recent change of +$1.21 million (+13.30%) on December 31, 2023. During the last 3 years, it has risen by +$9.41 million (+1046.50%). CORT annual total long term liabilities is now -64.85% below its all-time high of $29.32 million, reached on December 31, 2013.CORT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CORT Quarterly Long Term Liabilities
$19.21 M
+$1.64 M+9.36%
30 September 2024
Summary:
As of January 23, 2025, CORT quarterly total long term liabilities is $19.21 million, with the most recent change of +$1.64 million (+9.36%) on September 30, 2024. Over the past year, it has increased by +$8.34 million (+76.70%). CORT quarterly long term liabilities is now -54.54% below its all-time high of $42.24 million, reached on March 31, 2004.CORT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CORT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.3% | +76.7% |
| 3 y3 years | +1046.5% | +111.1% |
| 5 y5 years | +4212.6% | +111.1% |
CORT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2420.1% | at high | +4595.8% |
| 5 y | 5-year | at high | +2420.1% | at high | +4665.8% |
| alltime | all time | -64.8% | -54.5% |
Corcept Therapeutics Incorporated Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.21 M(+9.4%) |
| June 2024 | - | $17.56 M(+61.6%) |
| Mar 2024 | - | $10.87 M(+5.5%) |
| Dec 2023 | $10.31 M(+13.3%) | $10.31 M(-1.6%) |
| Sept 2023 | - | $10.47 M(+5.2%) |
| June 2023 | - | $9.95 M(+5.9%) |
| Mar 2023 | - | $9.40 M(+3.3%) |
| Dec 2022 | $9.10 M(+2124.2%) | $9.10 M(+33.3%) |
| Sept 2022 | - | $6.82 M(+37.0%) |
| June 2022 | - | $4.98 M(+62.4%) |
| Mar 2022 | - | $3.07 M(+650.1%) |
| Dec 2021 | $409.00 K(-54.5%) | $409.00 K(-1.0%) |
| Sept 2021 | - | $413.00 K(+2.5%) |
| June 2021 | - | $403.00 K(-59.5%) |
| Mar 2021 | - | $995.00 K(+10.7%) |
| Dec 2020 | $899.00 K(-60.7%) | $899.00 K(-35.6%) |
| Sept 2020 | - | $1.40 M(-25.8%) |
| June 2020 | - | $1.88 M(-2.5%) |
| Mar 2020 | - | $1.93 M(-15.7%) |
| Dec 2019 | $2.29 M(+857.7%) | $2.29 M(+815.6%) |
| Sept 2019 | - | $250.00 K(+2.0%) |
| June 2019 | - | $245.00 K(+2.5%) |
| Mar 2019 | - | $239.00 K(0.0%) |
| Dec 2018 | $239.00 K(>+9900.0%) | $239.00 K(>+9900.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(-100.0%) |
| June 2016 | - | $3.74 M(-57.1%) |
| Mar 2016 | - | $8.72 M(-30.4%) |
| Dec 2015 | $12.53 M(-48.8%) | $12.53 M(-22.3%) |
| Sept 2015 | - | $16.13 M(-16.8%) |
| June 2015 | - | $19.40 M(-12.3%) |
| Mar 2015 | - | $22.13 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $24.46 M(-16.6%) | $24.46 M(-5.9%) |
| Sept 2014 | - | $25.99 M(-6.0%) |
| June 2014 | - | $27.64 M(-2.1%) |
| Mar 2014 | - | $28.22 M(-3.8%) |
| Dec 2013 | $29.32 M(+1.0%) | $29.32 M(-2.7%) |
| Sept 2013 | - | $30.14 M(-0.3%) |
| June 2013 | - | $30.24 M(+4.6%) |
| Mar 2013 | - | $28.89 M(-0.5%) |
| Dec 2012 | $29.03 M(>+9900.0%) | $29.03 M(+2.5%) |
| Sept 2012 | - | $28.32 M(>+9900.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(-100.0%) |
| June 2009 | - | $1000.00(-75.0%) |
| Mar 2009 | - | $4000.00(-33.3%) |
| Dec 2008 | $6000.00(-62.5%) | $6000.00(-33.3%) |
| Sept 2008 | - | $9000.00(-25.0%) |
| June 2008 | - | $12.00 K(-14.3%) |
| Mar 2008 | - | $14.00 K(-12.5%) |
| Dec 2007 | $16.00 K(-44.8%) | $16.00 K(-15.8%) |
| Sept 2007 | - | $19.00 K(-13.6%) |
| June 2007 | - | $22.00 K(-15.4%) |
| Mar 2007 | - | $26.00 K(-10.3%) |
| Dec 2006 | $29.00 K(-31.0%) | $29.00 K(-9.4%) |
| Sept 2006 | - | $32.00 K(-11.1%) |
| June 2006 | - | $36.00 K(-7.7%) |
| Mar 2006 | - | $39.00 K(-7.1%) |
| Dec 2005 | $42.00 K | $42.00 K(-6.7%) |
| Sept 2005 | - | $45.00 K(+350.0%) |
| June 2005 | - | $10.00 K(-100.0%) |
| Mar 2004 | - | $42.24 M |
FAQ
- What is Corcept Therapeutics Incorporated annual total long term liabilities?
- What is the all time high annual total long term liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual total long term liabilities year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly long term liabilities year-on-year change?
What is Corcept Therapeutics Incorporated annual total long term liabilities?
The current annual total long term liabilities of CORT is $10.31 M
What is the all time high annual total long term liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total long term liabilities is $29.32 M
What is Corcept Therapeutics Incorporated annual total long term liabilities year-on-year change?
Over the past year, CORT annual total long term liabilities has changed by +$1.21 M (+13.30%)
What is Corcept Therapeutics Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of CORT is $19.21 M
What is the all time high quarterly long term liabilities for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total long term liabilities is $42.24 M
What is Corcept Therapeutics Incorporated quarterly long term liabilities year-on-year change?
Over the past year, CORT quarterly total long term liabilities has changed by +$8.34 M (+76.70%)